Advanced Asset Management Advisors’s Edwards Lifesciences EW Stock Holding History

Advanced Asset Management Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29,100	Closed	-$3.29M	–	92
2021 Q3	$3.29M	Hold	29,100	–	–	0.71%	48
2021 Q2	$3.01M	Hold	29,100	–	–	0.64%	48
2021 Q1	$2.43M	Hold	29,100	–	–	0.54%	52
2020 Q4	$2.65M	Hold	29,100	–	–	0.62%	49
2020 Q3	$2.32M	Hold	29,100	–	–	0.62%	50
2020 Q2	$2.01M	Hold	29,100	–	–	0.59%	50
2020 Q1	$1.83M	Hold	29,100	–	–	0.63%	49
2019 Q4	$2.26M	Hold	29,100	–	–	0.68%	48
2019 Q3	$2.13M	Hold	29,100	–	–	0.69%	47
2019 Q2	$1.79M	Buy	29,100 +9,000	+45%	+$544K	0.62%	45
2019 Q1	$1.28M	Hold	20,100	–	–	0.46%	58
2018 Q4	$1.03M	Hold	20,100	–	–	0.33%	73
2018 Q3	$1.17M	Hold	20,100	–	–	0.42%	48
2018 Q2	$975K	Hold	20,100	–	–	0.31%	65
2018 Q1	$935K	Hold	20,100	–	–	0.31%	63
2017 Q4	$755K	Buy	+20,100	New	+$738K	0.25%	77

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advanced Asset Management Advisors's EW Position: Q4 2021 in Review

Advanced Asset Management Advisors sold out of Edwards Lifesciences (EW) in Q4 2021, closing a stake of 29,100 shares — an estimated $3.29M sold.

Advanced Asset Management Advisors first reported a position in EW in Q4 2017 and held it in 16 quarters. The position peaked at $3.29M in Q3 2021. 1,319 funds tracked by Wall St. Rank hold EW as of Q4 2021.

Advanced Asset Management Advisors reported no remaining Edwards Lifesciences position as of Q4 2021 after selling out during the quarter.
Advanced Asset Management Advisors sold 29,100 Edwards Lifesciences shares in Q4 2021, an estimated $3.29M.
Advanced Asset Management Advisors first reported a position in Edwards Lifesciences in Q4 2017 and held it in 16 quarters.
Advanced Asset Management Advisors's Edwards Lifesciences position peaked at $3.29M in Q3 2021.
1,319 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on Advanced Asset Management Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.